Amit Sachdev - 17 Feb 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Patient Officer
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
17 Feb 2023
Net transactions value
-$1,024,389
Form type
4
Filing time
22 Feb 2023, 15:43:10 UTC
Previous filing
14 Feb 2023
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $1,024,389 -3,498 -4.8% $292.85 68,986 17 Feb 2023 Direct
holding VRTX Common Stock 882 17 Feb 2023 401(k)
holding VRTX Common Stock 8,861 17 Feb 2023 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.